Nano-X Imaging Future Growth
Future criteria checks 2/6
Nano-X Imaging is forecast to grow earnings and revenue by 45.9% and 41.3% per annum respectively while EPS is expected to grow by 48.1% per annum.
Key information
45.9%
Earnings growth rate
48.1%
EPS growth rate
Healthcare earnings growth | 18.9% |
Revenue growth rate | 41.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 05 Dec 2024 |
Recent future growth updates
Recent updates
We Think Some Shareholders May Hesitate To Increase Nano-X Imaging Ltd.'s (NASDAQ:NNOX) CEO Compensation
Dec 05Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?
Nov 25Nano-X Imaging: Bold Vision, Bearish Momentum, And High Investor Risk
Sep 29Is Nano-X Imaging (NASDAQ:NNOX) Weighed On By Its Debt Load?
Apr 05Nano-X Imaging: System Deployments Finally Begin
Apr 01Nano-X Imaging gains on FDA submission for new digital X-ray technology
Sep 28Nano-X Imaging Q2 Earnings Preview
Aug 15Nano-X: Too Controversial To Buy
Jun 30Nano-X Imaging Q4 2021 Earnings Preview: Insight Coming Regarding This Binary Play
Mar 30Monday's Drop Isn't Likely The Last One For Nano-X
Dec 28Nano-X Imaging Stock Is A No-No Buy
Oct 11We're Interested To See How Nano-X Imaging (NASDAQ:NNOX) Uses Its Cash Hoard To Grow
Aug 20Nanox submits 510(k) application for first version of Nanox.ARC 3-D in U.S.
Jun 17We're Not Worried About Nano-X Imaging's (NASDAQ:NNOX) Cash Burn
May 05Here's What Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Shareholder Ownership Structure Looks Like
Mar 08Nano-X Imaging lower 10% on additional information request by FDA on Nanox.ARC version
Feb 01Nano-X Imaging (NASDAQ:NNOX) Is In A Strong Position To Grow Its Business
Jan 13Nano-X Imaging and USARAD extend strategic collaboration
Jan 05Nano-X Vision Under The X-Ray
Dec 09What Type Of Shareholders Make Up Nano-X Imaging Ltd.'s (NASDAQ:NNOX) Share Registry?
Nov 21Nano-X Imaging EPS misses by $0.12
Nov 09NANO-X Imaging: Novel Technology Or Outdated Technology?
Nov 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 94 | -16 | N/A | N/A | 1 |
12/31/2026 | 98 | -24 | N/A | 19 | 3 |
12/31/2025 | 31 | -44 | N/A | -14 | 3 |
12/31/2024 | 12 | -53 | N/A | -32 | 3 |
9/30/2024 | 11 | -50 | -41 | -39 | N/A |
6/30/2024 | 10 | -57 | -44 | -42 | N/A |
3/31/2024 | 10 | -61 | -45 | -44 | N/A |
12/31/2023 | 10 | -61 | -48 | -45 | N/A |
9/30/2023 | 10 | -103 | -49 | -47 | N/A |
6/30/2023 | 10 | -101 | -45 | -42 | N/A |
3/31/2023 | 9 | -103 | -48 | -43 | N/A |
12/31/2022 | 9 | -113 | -51 | -43 | N/A |
9/30/2022 | 8 | -82 | -63 | -50 | N/A |
6/30/2022 | 5 | -77 | -65 | -49 | N/A |
3/31/2022 | 3 | -71 | -66 | -45 | N/A |
12/31/2021 | 1 | -62 | -61 | -38 | N/A |
9/30/2021 | N/A | -59 | N/A | N/A | N/A |
6/30/2021 | N/A | -56 | N/A | N/A | N/A |
3/31/2021 | N/A | -49 | N/A | N/A | N/A |
12/31/2020 | N/A | -44 | -36 | -22 | N/A |
9/30/2020 | N/A | -44 | -13 | -12 | N/A |
6/30/2020 | N/A | -35 | -9 | -9 | N/A |
3/31/2020 | N/A | -29 | N/A | N/A | N/A |
12/31/2019 | N/A | -23 | -6 | -6 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: NNOX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: NNOX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: NNOX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: NNOX's revenue (41.3% per year) is forecast to grow faster than the US market (9% per year).
High Growth Revenue: NNOX's revenue (41.3% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NNOX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/02 00:34 |
End of Day Share Price | 2025/01/02 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nano-X Imaging Ltd. is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Benjamin Haynor | Alliance Global Partners |
Scott Henry | Alliance Global Partners |
Ravi Misra | Berenberg |